SEARCH

SEARCH BY CITATION

  • 1
    Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen F, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cy-tolytic T lymphocytes on a human melanoma. Science 1991; 254: 16437.
  • 2
    Robbins PF, Kawakami Y. Human tumor antigens recognized by T cells. Curr Opin Immunol 1996; 8: 62836.
  • 3
    Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183: 7259.
  • 4
    Matis LA, Shu S, Groves ES, Zinn S, Chou T, Kruisbeek AM, Rosenstein M, Rosenberg SA. Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human inter-leukin 2: correlation with clonal IL 2 receptor expression. Immunology 1986; 136: 3496501.
  • 5
    Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, van der Eb AJ, Melief CJ. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 1989; 59: 60314.
  • 6
    Nishimura T, Togashi Y, Goto M, Yagi H, Uchiyama Y, Hashimoto Y. Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2. Cancer Immunol Immunother 1986; 21: 128.
  • 7
    Disis ML, Smith JW, Murphy AE, Chen W, Cheever MA. In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein. Cancer Res 1994; 54: 10716.
  • 8
    Umano Y, Tsunoda T, Tanaka H, Matsuda K, Yamaue H, Tanimura H. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53. Br J Cancer 2001; 84: 10527.
  • 9
    Bakker AB, Marland G, De Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 1995; 55: 53304.
  • 10
    Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 1995; 154: 39618.
  • 11
    Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994; 91: 35159.
  • 12
    Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8 T cells into cytotoxic CD8 T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 2719.
  • 13
    Nishimura T, Iwakabe K, Sekimoto M, Ohmi Y, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A. Distinct role of antigen-specific Thelper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med 1999; 190: 61727.
  • 14
    Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, Ohta A, Koda T, Nishimura S. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol 2000; 46: S5261.
  • 15
    Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 1727.
  • 16
    Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 1988; 335: 2714.
  • 17
    Morita S, Kojima T, Kitamura T. PLAT-E; an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 10636.
  • 18
    Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL, Gorman DM, Nolan GP, Miyajima A, Kitamura T. Applications of retrovirus-mediated expression cloning. Exp Hematol 1996; 24: 3249.
  • 19
    Fujio K, Misaki Y, Setoguchi K, Morita S, Kawahata K, Kato I, Nosaka T, Yamamoto K, Kitamura T. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the αβ TCR complex. J Immunol 2000; 165: 52832.
  • 20
    Kessels HWHG, Wolkers MC, van den Boom MD, van der Valk MA, Schumacher TNM. Immunotherapy through TCR gene transfer. Nat Immunol 2001; 2: 95761.
  • 21
    Stanislawski T, Voss R-H, Lotz C, Sadovnikova E, Willemsen RA, Kuball J, Ruppert T, Bolhuis RLH, Melief CJ, Huber C, Stauss HJ, Theobald M. Circumventing human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001; 2: 96270.
  • 22
    Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 1999; 163: 50713.
  • 23
    Cooper LJN, Kalos M, Lewinsohn DA, Riddell SR, Greenberg PD. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J Virol 2000; 74: 820712.
  • 24
    Yang L, Qin X-F, Baltimore D, Parijs LV. Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proc Natl Acad Sci USA 2002; 99: 62049.
  • 25
    Oki M, Ando K, Hagihara M, Miyatake H, Shimizu T, Miyoshi H, Nakamura Y, Matsuzawa H, Sato T, Ueda Y, Gansuvd B, Kato S, Hotta T. Efficient lentiviral transduction of human cord blood CD34 cells followed by their expansion and differentiation into dendritic cells. Exp Hematol 2001; 29: 12107.
  • 26
    Indraccolo S, Habeler W, Tisato V, Stievano L, Piovan E, Tosello V, Esposito G, Wagner R, Uberla K, Chieco-Bianchi L, Amadori A. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Cancer Res 2002; 62: 6099107.
  • 27
    Pittet MJ, Speiser DE, Lienard D, Valmori D, Guillaume P, Dutoit V, Rimoldi D, Lejeune F, Cerottini JC, Romero P. Expansion and functional maturation of human tumor antigen-specific CD8+T cells after vaccination with antigenic peptide. Clin Cancer Res 2001; 7: 796s803s.
  • 28
    Valmori D, Dutoit V, Lienard D, Rimoldi D, Pittet MJ, Champagne P, Ellefsen K, Sahin U, Speiser D, Lejeune F, Cerottini JC, Romero P. Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res 2000; 60: 4499506.
  • 29
    Lee KH, Wang E, Nielsen MB, Wunderlich J, Migueles S, Connors M, Steinberg SM, Rosenberg SA, Marincola FM. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol 1999; 163: 6292300.